Angiodynamics (ANGO) Operating Income (2010 - 2026)
Angiodynamics (ANGO) posted Operating Income of -$10.2 million for Q2 2026, up 21.28% on a QoQ basis from -$13.0 million in Q1 2026, and down 76.14% year-over-year from -$42.7 million in Q2 2025.
Angiodynamics (ANGO) Operating Income (2010 - 2026) Analysis & Trends
Angiodynamics' Operating Income history runs 17 years deep, the most recent figure standing at -$10.2 million for Q2 2026.
- Quarterly Operating Income fell 76.14% year-over-year to -$10.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$39.9 million (changed 0.07% YoY) and the FY2026 annual result came in at -$39.9 million, changed 0.07% from the prior year.
- Operating Income was -$10.2 million for Q2 2026 at Angiodynamics, up from -$13.0 million in the prior quarter.
- Across five years, Operating Income topped out at $35.0 million in Q3 2023 and bottomed at -$199.9 million in Q1 2024.
- A 5-year average of -$18.6 million and a median of -$10.4 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income surged 363.36% — and 2024, when it sank 2138.98%.
- Angiodynamics' Operating Income stood at -$8.1 million in 2022, then sank by 61.68% to -$13.1 million in 2023, then rose by 15.44% to -$11.1 million in 2024, then jumped by 44.79% to -$6.1 million in 2025, then plunged by 66.45% to -$10.2 million in 2026.
- Business Quant data shows ANGO's Operating Income at -$10.2 million in Q2 2026, -$13.0 million in Q1 2026, and -$6.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 2.65 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 93.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 422.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 499.81 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -31.00 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 81.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 141.96 Mn |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | -10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -10.20 Mn |
| Feb 28, 2026 | -12.95 Mn |
| Nov 30, 2025 | -6.13 Mn |
| Aug 31, 2025 | -10.66 Mn |
| May 31, 2025 | -5.79 Mn |
| Feb 28, 2025 | -9.97 Mn |
| Nov 30, 2024 | -11.09 Mn |
| Aug 31, 2024 | -13.10 Mn |
| May 31, 2024 | -14.45 Mn |
| Feb 29, 2024 | -199.90 Mn |
| Nov 30, 2023 | -13.12 Mn |
| Aug 31, 2023 | 35.03 Mn |
| May 31, 2023 | -20.84 Mn |
| Feb 28, 2023 | -8.93 Mn |
| Nov 30, 2022 | -8.12 Mn |
| Aug 31, 2022 | -13.30 Mn |
| May 31, 2022 | -6.40 Mn |
| Feb 28, 2022 | -5.30 Mn |
| Nov 30, 2021 | -8.68 Mn |
| Aug 31, 2021 | -8.10 Mn |